Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Once homeless, America Arevalo helps participants in AARP ...
JURUPA VALLEY, CA - February 13, 2026 - PRESSADVANTAGE - A newly released educational resource provides clinically ...
First Lady Anna Stein is emphasizing the role of prison reentry and substance abuse treatment programs in public safety, aiming to attract volunteers in the absence of additional state funding. First ...
Beast Industries acquired Step to expand into youth-focused financial services. Beast Industries did not disclose the amount it used to acquired Step, which counts major backers such as Stripe. The ...
Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...
The US Department of Health and Human Services and hospitals groups are scrapping a legal fight over a drug rebate pilot after federal officials said they would take another look at the program.
The U.S. Department of Health and Human Services will launch a $100 million pilot program designed to address addiction and homelessness in eight unspecified communities, HHS Secretary Robert F.
Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. Dr. Marty Makary, commissioner of the Food and ...
Health Secretary Robert F. Kennedy Jr. said addiction is a “spiritual disease” that calls out for the involvement of religious organizations. By Ellen Barry Health Secretary Robert F. Kennedy Jr.
Today, a brief rundown of news from The Food and Drug Administration and AstraZeneca, as well as updates from Acadia Pharmaceuticals and MeiraGTx that you may have missed. Some two dozen biotech ...
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — At an employee town ...
Amid an outpouring of industry investments in U.S. drug production, the FDA has launched a new program designed to significantly reduce the complexities involved in setting up domestic manufacturing ...